(61) developed the iREX (Integrated Raman Spectroscopy EXO) biosensor, which is capable of multiple quantitatively analyzing proteins of exosomes (MUC1, HER2 and CEA) in clinical plasma samples from breast cancer patients (Figure 1). This evidence concerns the gene CEACAM5 and breast cancer.